The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia

Disease relapse represents by far the most frequent cause of hematopoietic cell transplantation (HCT) failure. Patients with acute leukemia suffering relapse after HCT have limited conventional treatment options with little possibility of cure and represent, de facto, suitable candidates for the eva...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Enrico Maffini, Margherita Ursi, Francesco Barbato, Michele Dicataldo, Marcello Roberto, Elena Campanini, Elisa Dan, Francesco De Felice, Serena De Matteis, Gianluca Storci, Massimiliano Bonafè, Mario Arpinati, Francesca Bonifazi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-11-01
Colecção:	Frontiers in Oncology
Assuntos:	allogeneic hematopoietic cell transplantation (HCT) acute myeloid leukemia (AML) disease relapse donor lymphocyte infusion hypomethylating agents relapse prevention in AML receiving allogeneic hematopoietic cell transplantation
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1066285/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!